Mili Gupta1, Rashi Chaturvedi, Ashish Jain. 1. Department of Biochemistry, Dr. Harvansh Singh Judge, Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, India. miligupta8@yahoo.com
Abstract
OBJECTIVE: Monocyte chemoattractant protein-1 (MCP-1) is an important chemokine responsible for the initiation, regulation and mobilization of monocytes to the active sites of severe periodontal inflammation. The present study aims at evaluating the levels of MCP-1 in GCF, saliva and serum and to analyze the changes following phase I periodontal therapy. Assessment of possible correlations between levels of MCP-1 in the three biological fluids was also done. METHODS: Fifteen healthy and 30 patients of severe chronic periodontitis (diseased) participated in the study. Patients of the diseased group underwent scaling/root planing. Evaluation of PI, GI, PD, CAL and collection of samples of GCF, serum and saliva was done at baseline and 6 weeks following periodontal therapy. MCP-1 levels were quantified in all samples using ELISA. RESULTS: Compared to healthy controls, MCP-1 levels were statistically significantly higher in GCF (p<0.001), saliva (p=0.002) and serum (p<0.001) in subjects with chronic periodontitis. Levels of MCP-1 in all the three fluids decreased significantly in patients after periodontal therapy (p<0.001). There was a significant positive correlation between MCP-1 levels in GCF, saliva and serum in patients of chronic periodontitis both pre (r>0.9) and post-treatment (r>0.6). CONCLUSIONS: The results suggest that levels of MCP-1 in GCF and saliva can be reliable indicators of severity of periodontal destruction and their serum levels reflect the systemic impact of this local inflammatory disease thereby strengthening the reciprocal oro-systemic association.
OBJECTIVE:Monocyte chemoattractant protein-1 (MCP-1) is an important chemokine responsible for the initiation, regulation and mobilization of monocytes to the active sites of severe periodontal inflammation. The present study aims at evaluating the levels of MCP-1 in GCF, saliva and serum and to analyze the changes following phase I periodontal therapy. Assessment of possible correlations between levels of MCP-1 in the three biological fluids was also done. METHODS: Fifteen healthy and 30 patients of severe chronic periodontitis (diseased) participated in the study. Patients of the diseased group underwent scaling/root planing. Evaluation of PI, GI, PD, CAL and collection of samples of GCF, serum and saliva was done at baseline and 6 weeks following periodontal therapy. MCP-1 levels were quantified in all samples using ELISA. RESULTS: Compared to healthy controls, MCP-1 levels were statistically significantly higher in GCF (p<0.001), saliva (p=0.002) and serum (p<0.001) in subjects with chronic periodontitis. Levels of MCP-1 in all the three fluids decreased significantly in patients after periodontal therapy (p<0.001). There was a significant positive correlation between MCP-1 levels in GCF, saliva and serum in patients of chronic periodontitis both pre (r>0.9) and post-treatment (r>0.6). CONCLUSIONS: The results suggest that levels of MCP-1 in GCF and saliva can be reliable indicators of severity of periodontal destruction and their serum levels reflect the systemic impact of this local inflammatory disease thereby strengthening the reciprocal oro-systemic association.
Authors: Jason C Lenzo; Neil M O'Brien-Simpson; Rebecca K Orth; Helen L Mitchell; Stuart G Dashper; Eric C Reynolds Journal: Infect Immun Date: 2016-08-19 Impact factor: 3.441
Authors: Kristine Y DeLeon-Pennell; Rugmani Padmanabhan Iyer; Osasere K Ero; Courtney A Cates; Elizabeth R Flynn; Presley L Cannon; Mira Jung; De'Aries Shannon; Michael R Garrett; William Buchanan; Michael E Hall; Yonggang Ma; Merry L Lindsey Journal: JCI Insight Date: 2017-09-21
Authors: E Davidovich; A Hevroni; L Tzur Gadassi; A Spierer-Weil; O Yitschaky; D Polak Journal: Clin Oral Investig Date: 2021-10-22 Impact factor: 3.573
Authors: Mengjie Wu; Andrey Ethan Rubin; Tianhong Dai; Rene Schloss; Osman Berk Usta; Alexander Golberg; Martin Yarmush Journal: Adv Wound Care (New Rochelle) Date: 2020-12-18 Impact factor: 4.947